Dublin-based pharma firm receives go-ahead for first-ever spray for opoid overdose.
The US Food and Drug Administration approved the first-ever nasal spray emergency treatment for opioid overdose on Wednesday.
The spray, developed by privately held Adapt Pharma, the latest venture of serial pharmaceuticals entrepreneur Seamus Mulligan, uses naloxone, a drug used to treat opioid overdose for nearly 45 years but approved only in injectable forms.
Data from the Centers for Disease Control and Prevention indicates opioid overdose led to about 23,500 deaths in the United States in 2013, a four-fold jump from 1999.
Source: Irish Times, 19/11/15
Posted by drugs.ie on 11/20 at 09:45 AM in
Share this:
(0) Comments
Safer Student Nights
eBulletin
Poll
